Siemens Healthineers (OTCMKTS:SMMNY) Releases Earnings Results, Beats Expectations By $0.02 EPS

Siemens Healthineers (OTCMKTS:SMMNY) posted its earnings results on Thursday. The company reported $0.40 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.02, Zacks reports.

Siemens Healthineers Stock Performance

Shares of SMMNY traded down $0.34 during trading hours on Thursday, hitting $24.98. 51,354 shares of the company were exchanged, compared to its average volume of 127,643. Siemens Healthineers has a fifty-two week low of $19.20 and a fifty-two week high of $27.46. The firm’s fifty day moving average is $22.54 and its 200 day moving average is $21.95.

Analysts Set New Price Targets

Several equities analysts recently commented on SMMNY shares. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Siemens Healthineers in a research note on Tuesday, August 18th. Royal Bank Of Canada reiterated an “outperform” rating on shares of Siemens Healthineers in a research note on Friday, October 16th. Zacks Research downgraded shares of Siemens Healthineers from a “hold” rating to a “strong sell” rating in a report on Thursday, October 1st. Finally, Citigroup restated a “buy” rating on shares of Siemens Healthineers in a research report on Tuesday, October 13th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy”.

About Siemens Healthineers

Siemens Healthineers AG is a Germany-based medical technology company that develops products, services and digital solutions for healthcare providers. Its portfolio supports diagnostic, therapeutic and monitoring activities across hospitals, clinics, laboratories and other healthcare settings.

The company’s offerings include magnetic resonance imaging, computed tomography, X-ray, molecular imaging and ultrasound systems, as well as laboratory diagnostics, point-of-care testing and related software.